Serina Therapeutics

Company snapshot

Serina Therapeutics is a privately held biotechnology company located in Huntsville, Alabama. We have developed a proprietary, clinically-validated polymer technology based on the water-soluble polymer poly(oxazoline). We call it POZ for short. Please visit our website at www.serinatherapeutics.com and review the exciting work we are doing in vaccines, Parkinson's disease, pain, oncology and canna

• 2 active pipeline program(s) linked via ClinicalTrials.gov.
• 25 US patent(s) indexed to this assignee profile.
• 2 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Serina Therapeutics. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Serina Therapeutics.

1. Jun 5, 2026 Clinical update

   SER-252 (PEOZ-apomorphine) — Phase 1

2. Jun 5, 2026 Clinical update

   SER-214 — Phase 1

3. Aug 12, 2025 Patent grant

   Polyoxazoline-drug conjugates with novel pharmacokinetic properties

4. Aug 12, 2025 Patent grant

   Polyoxazoline-drug conjugates with novel pharmacokinetic properties

5. Feb 25, 2025 Patent grant

   Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same

View all clinical trial activity →

• What is Serina Therapeutics?

  Serina Therapeutics is a pharma organization headquartered in Huntsville, USA. It trades on NYSE under ticker SER. Primary therapeutic focus areas include Parkinson's Disease, PARKINSON DISEASE (Disorder). NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 25 pate

• Is Serina Therapeutics publicly traded?

  Yes. Serina Therapeutics is listed with ticker SER on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Serina Therapeutics develop or market?

  We link 3 drug profile(s) where Serina Therapeutics is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/serina-therapeutics#company-drugs.

• What are the latest developments for Serina Therapeutics?

  In the last 12 months our linked public records show 2 trial program update(s) and 2 US patent grant(s) tied to this profile.

• What therapeutic areas does Serina Therapeutics focus on?

  Serina Therapeutics focuses on Parkinson's Disease, PARKINSON DISEASE (Disorder) based on our analysis of their pipeline programs and drug development activities.